Actinium Pharmaceuticals Inc (ATNM) stock is down -15.83% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ATNM stock a score of 68 out of a possible 100.
That rank is primarily influenced by a long-term technical score of 72. ATNM's rank also includes a fundamental score of 70. In addition to the average rating from Wall Street analysts, ATNM stock has a mean target price of $35.00. This means analysts expect the stock to rise 448.59% over the next 12 months. The short-term technical score for ATNM is 62. ATNM has an Overall Score of 68. Find out what this means to you and get the rest of the rankings on ATNM!